Exploring a Motor Learning Technique Based on the Mirror Motor Neuron System

June 30, 2017 updated by: National Institute of Neurological Disorders and Stroke (NINDS)

Background:

  • Techniques that teach finger movements are commonly used to explore how humans learn to move. Researchers have designed a simple, new method of learning finger movements, which will be explored for the first time in this study. The method is based on how individuals mimic other people's movements.
  • Previous studies have shown that a brain protein called brain-derived neurotrophic factor (BDNF) may be important in movement and in learning. There are normal variations in the gene for BDNF. As an optional component, this study will also look at whether these gene variations are associated with differences in movement learning.

Objectives:

  • To compare the new motor learning technique with a classic technique to test its usefulness.
  • To examine whether genetic variations have an effect on motor learning.

Eligibility:

  • Healthy volunteers between the ages of 18 and 50, who are right-handed.

Design:

  • The study will involve two visits to the National Institutes of Health Clinical Center.
  • Visit 1: Medical and neurologic examination to determine whether the volunteer is eligible to participate further in the study. This screening visit will take about 1 hour.
  • Visit 2: Volunteers will perform a motor learning task by interacting with a computer program. In response to images on the computer monitor, volunteers will press buttons on the keyboard as quickly and accurately as possible. The motor learning task will last up to 3 hours.
  • If a volunteer agrees to genetic testing, researchers will also draw blood for study. Genetic testing is not required to participate in the motor learning parts of the study.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Completed

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Detailed Description

Objective

Humans develop skilled movements such as using a spoon or dancing a waltz through a process known as "motor learning. Harnessing this innate process for its therapeutic potential is an attractive strategy to help patients suffering from diseases of movement disorders, yet we do not yet fully understand the normal phenomenon. This study will utilize new paradigms to explore the physiology of motor learning. It will test the validity of a traditional motor learning task that has been modified to invoke the mirror neuron system and odor conditioning. Additionally, by taking advantage of the unique opportunity to assess motor learning awareness immediately following the task, it will also explore this behavioral-cognitive relationship. Thus, this work will lay the foundation for further physiologic characterization of a novel motor learning technique and may support the development of future therapies.

Study Population

We will study up to one hundred fifty-two healthy, right-handed volunteers who are 18 to 50 years old.

Design

In phase I of the study, volunteers will be seated in front of a computer monitor with their right hands on a keyboard and respond to visual cues presented on the monitor by pressing the associated, finger-specific keys as quickly and accurately as possible. Each volunteer will be presented only the standard visuospatial or the novel mirror cues, defining the two reaction time task paradigms and experimental groups. In phases II and III of the study, a similar task will take place while subjects undergo magnetic resonance imaging scanning either in the presence or absence of an odor. In addition to the motor learning tasks above, volunteers will have the option to participate in genetic testing for normal genetic variability that may affect motor learning.

Outcome Measure

The primary outcomes are motor learning and awareness, which will be measured by the key-press reaction time and accuracy, respectively.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Observational

Enrollment (Actual)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
76

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • Maryland
      • Bethesda, Maryland, United States, 20892
        • National Institutes of Health Clinical Center, 9000 Rockville Pike

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

18 years to 50 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

  • INCLUSION CRITERIA:
  • Age 18-50 years
  • Right-handedness

EXCLUSION CRITERIA:

  • Arthritis or other physically limiting disability, amputation, or significant trauma of either hand
  • Professional musician or stenographer
  • Persistent neurologic deficit of cognition, movement, or sensation or any history of a central nervous system lesion
  • Regular use of any neurotropic or psychotropic medication (e.g., narcotic analgesic, anxiolytic, anti-histamine) or any use within twenty-four hours of the motor learning task.
  • Blindness or visual acuity lower than necessary to distinguish visual stimuli on the display monitor
  • Impaired decisional capacity or inability to provide informed consent
  • Previous experience with a serial reaction time task type of study
  • Nasopharyngeal illness, injury, or dysfunction (Phase III only)
  • Inability to smell odorized air during screening exam (Phase III only)
  • Pregnancy (Phases II and III only)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
National Institute of Neurological Disorders and Stroke (NINDS)

Investigators

Investigators

A researcher involved in a clinical study. Related terms include site principal investigator, site sub-investigator, study chair, study director, and study principal investigator.
  • Principal Investigator: Bibiana Bielekova, M.D., National Institute of Neurological Disorders and Stroke (NINDS)

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
March 25, 2009

Study Completion

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
May 3, 2012

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
March 28, 2009

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
March 28, 2009

First Posted (Estimate)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
March 31, 2009

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
July 2, 2017

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
June 30, 2017

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
May 3, 2012

More Information

Terms related to this study

Keywords

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • 090098
  • 09-N-0098

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings